Effects of pregnancy and delivery on disease activity in multiple sclerosis

Article Abstract:

Pregnant women with multiple sclerosis should begin taking interferon beta again as soon as their pregnancy is over. A 1998 study found that a group of pregnant women with multiple sclerosis were less likely to have a relapse during the pregnancy but more likely to have one after childbirth. This could compromise the mother's ability to care for the infant. Interferon beta and glatiramer acetate are both used in the treatment of multiple sclerosis but neither should be used during pregnancy.

Health aspects, Editorial, Pregnancy

---

Robotic surgery - Squeezing into tight places

Article Abstract:

The advantages of using robotic systems in surgery are discussed. Robot-assisted surgeons will be able to see real-time, three-dimensional scanner images electronically superimposed over the operative field that is displayed on the monitor and this will help the surgeon to determine the exact location of a tumor and more readily avoid damaging vital structures.

Usage, Robotic surgery

---

Multiple Sclerosis: The plaque and its pathogenesis

Article Abstract:

A study on the knowledge of the pathogenesis of the inflammatory and neurodegenerative elements of the multiple sclerosis plaque is illustrated. It is believed that the histopathological hallmark originates from a breach in the integrity of the blood-brain barrier in a person who is genetically predisposed to the disease.

Similar abstracts:

• Abstracts: The effect of surface finishing and storage solutions on the color stability of resin-based composites. Making provisional restorations easy, predictable and economical
• Abstracts: Neuroprotective and anti-human immunodeficiency virus activity of minocycline. New avenues of exploration for erythropoietin
• Abstracts: Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load
• Abstracts: Beyond fraud - Stem-cell research continues. Tackling medical futility in Texas. The leading edge of stem cell therapeutics
• Abstracts: The quest for women's PPE. Manufacturers and distributors. New products

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.